Corporate Profile

Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and formulations. As a result, Impel's therapies have the potential to improve the onset of symptomatic relief for a spectrum of conditions.
Impel's mission is to create and provide transformative therapies for people suffering from diseases with high unmet medical needs. We have pioneered an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.  
To learn more about Impel Pharmaceuticals, please visit our website at

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

Latest Earnings

Show all